SENSEX NIFTY
78041.59 23587.5
-1,176.46 (-1.49%)
-364.20 (-1.52%)
 

NOTICES


Heading View
  SEBI Circular No. CIR/MRD/DP/01/2014 Dated 7th January, 2014   Click here
  SEBI Circular No. SEBI/HO/MIRSD/MIRSD2/CIR/P/2016/95, Dated 26th September, 2016.   Click here
DETACH
Increase
Minus
IPO Synopsis Senores Pharmaceuticals Ltd
Registered Office : #.1101-1103 11th Flr South Twr,Ambali Bopal Road, Ahmedabad - 380054, Gujarat, India.
Phone : +91-79-2999 9857   Fax:
Email : cs@senorespharma.com
Website :www.senorespharma.com
Initial public offering of up to [*] equity shares of face value of Rs. 10 each ("Equity Shares") of Senores Pharmaceuticals Limited ("The Company" or the "Issuer") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) ("Offer Price") aggregating up to Rs. [*] crores (the "Offer"). The offer comprises of a fresh issue of upto [*] equity shares by the company aggregating upto Rs. 500.00 crores (the "Fresh Issue") and an offer for sale of up to 2,100,000 equity shares (the "Offered Shares") aggregating up to Rs. [*] crores (the "Offer for Sale"), comprising up to 250,000 equity shares aggregating to Rs. [*] crores by Swapnil Jatinbhai Shah, up to 550,000 equity shares aggregating to Rs. [*] crores by Ashokkumar Vijaysinh Barot, up to 300,000 equity shares aggregating to Rs. [*] crores by Sangeeta Mukur Barot and up to 1,000,000 equity shares aggregating to Rs. [*] crores by Prakash M Sanghvi (the "Selling Shareholders"). The offer shall constitute [*] % of the post-offer paid-up equity share capital of the company. The offer includes a reservation of up to 75,000 equity shares, aggregating up to Rs. [*] crores (constituting [*] of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". Price Band: Rs. 372 to Rs. 391 per equity share of face value of Rs. 10 each. The Floor price is 37.20 times the face value of the equity shares and cap price is 39.10 times the face value of the equity shares. Bid can be made for a minimum of 38 equity shares and in multiples of 38 equity shares.  
Issue Money Payable On
Opens On Closes On Application Allotment
 20-Dec-24  24-Dec-24  372.00-391.00  0.00-0.00
Minimum Application for shares in Nos :  38   Further Multiples of :  38
  Rs Cr Lead Managers to the Issue
Project Cost  0.00 Ambit Pvt Ltd
Project Financed through Current Offer  578.12  
Post Issue Equity Share Capital  46.05  
Issue Price  372.00  
Projects
 Funding the capital expenditure requirements by investment in of one of your its subsidiary Havix,for setting up a mfg facility for the production of sterlie injection in its Atlanta Facility  Re-payment/pre-payment in full or in part of certain borrowings availed by the company and its subsidiary namely Havix Ratnatris and PSI
 Funding the working capital requirements of the company and its subsidiary namely SPI ad Ratnatris  Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes
 Investment in its subsidiary namely Havix for re-payment/pre-payment in full or in part of certain borrowings availd by the subsidiaries  Investment in its subsidiary namely SPI and Ratnatri to fund their working capital requirements
Promoted By
 Swapnil Jatinbhai
 Ashokkumar Vijaysingh Barot
 Anar Swapnil Shah
Listing At
 BSE
 NSE
Registrar to the Issue
No Data available..!
 
Attention Investors: No need to issue cheques by investors while subscribing to IPO. just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. | Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.' "
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Dear Clients: We are here with requesting you to submit your separate e-mail id to receive communications/reports, by submitting account modification form in this regards or if you have registered your family member e-mail id with us, please submit declaration in this regards. Further, if you have not registered e-mail id/mobile number with us, please register it by submitting account modification form which facilitates you to receive all the data/reports electronically. If you require any clarification, please feel free to call Mr. Hemant Shah on 9004603818 or email us at kyc@swcapital.in
Feedback | Back Office | Downloads | KYC | Disclaimer | Privacy Policy | Investor Grievances | Communique | Tariff Structure |
SCORES| Opening A Account| Filing A Complaints|
Copyright © 2011 -SW Capital Pvt Ltd. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)